{"ALNY": {"Ticker": "ALNY", "Company": "32", "Sector": "dfs", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Cantor Fitzgerald", "Rating_Change": "Neutral", "Target_Change": "$175"}, {"Date": "2022-06-27", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-06-07", "Rating": "Initiated", "Organization": "William Blair", "Rating_Change": "Outperform", "Target_Change": ""}, {"Date": "2022-04-25", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$210 to $178"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Guggenheim", "William Blair", "Morgan Stanley", "Cantor Fitzgerald"], "Price_Target": 86.25}, "AMD": {"Ticker": "AMD", "Company": "Advanced Micro Devices", "Sector": "Information Technology", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Positive", "Target_Change": "$140 to $120"}, {"Date": "2022-06-30", "Rating": "Upgrade", "Organization": "Northland Capital", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$97 to $95"}, {"Date": "2022-06-22", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$103"}, {"Date": "2022-05-17", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$98 to $140"}, {"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Strong Buy", "Target_Change": "$160"}], "Score": 1.6, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Northland Capital", "Morgan Stanley", "Piper Sandler", "Susquehanna", "Raymond James"], "Price_Target": 123.6}, "GOOG": {"Ticker": "GOOG", "Company": "Alphabet (Class C)", "Sector": "Communication Services", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$3200 to $3000"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Cowen"], "Price_Target": 3000.0}, "AMZN": {"Ticker": "AMZN", "Company": "Amazon", "Sector": "Consumer Discretionary", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform", "Target_Change": "$170 to $145"}, {"Date": "2022-06-29", "Rating": "Initiated", "Organization": "Redburn", "Rating_Change": "Buy", "Target_Change": "$270"}, {"Date": "2022-06-01", "Rating": "Resumed", "Organization": "JMP Securities", "Rating_Change": "Mkt Outperform", "Target_Change": "$3600 to $3450"}, {"Date": "2022-04-29", "Rating": "Reiterated", "Organization": "Monness Crespi & Hardt", "Rating_Change": "Buy", "Target_Change": "$4500 to $3700"}, {"Date": "2022-04-20", "Rating": "Resumed", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$4115 to $4100"}, {"Date": "2022-04-19", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Neutral", "Target_Change": "$3000"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "A", "Analists": ["JMP Securities", "Monness Crespi & Hardt", "Citigroup", "Rosenblatt", "Redburn", "Telsey Advisory Group"], "Price_Target": 2444.17}, "ANET": {"Ticker": "ANET", "Company": "Arista Networks", "Sector": "Information Technology", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Buy", "Target_Change": "$140"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Rosenblatt"], "Price_Target": 140.0}, "BBWI": {"Ticker": "BBWI", "Company": "Bath & Body Works Inc.", "Sector": "Consumer Discretionary", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Strong Buy", "Target_Change": "$45"}, {"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": ""}, {"Date": "2022-06-30", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$58"}, {"Date": "2022-06-29", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$63 to $30"}, {"Date": "2022-05-02", "Rating": "Upgrade", "Organization": "Cowen", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$82"}], "Score": 0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["JP Morgan", "Piper Sandler", "Evercore ISI", "Cowen", "Raymond James"], "Price_Target": 42.0}, "CZR": {"Ticker": "CZR", "Company": "Caesars Entertainment", "Sector": "Consumer Discretionary", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2022-06-29", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$56"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Barclays", "KeyBanc Capital Markets"], "Price_Target": 27.0}, "CE": {"Ticker": "CE", "Company": "Celanese", "Sector": "Materials", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform to Sector Perform", "Target_Change": "$200 to $116"}, {"Date": "2022-06-27", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Underperform", "Target_Change": "$105"}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["RBC Capital Mkts", "Credit Suisse"], "Price_Target": 110.5}, "CTAS": {"Ticker": "CTAS", "Company": "Cintas Corporation", "Sector": "Industrials", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$393"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Wells Fargo"], "Price_Target": 393.0}, "CSCO": {"Ticker": "CSCO", "Company": "Cisco Systems", "Sector": "Information Technology", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Neutral", "Target_Change": "$48"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$65 to $52"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$59 to $46"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Neutral", "Target_Change": "$57 to $43"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Oppenheimer", "Rating_Change": "Outperform", "Target_Change": "$60 to $50"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$59 to $46"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$67 to $62"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$65 to $52"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$62 to $50"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$59 to $51"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$72 to $60"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Sell", "Target_Change": "$45 to $40"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$62 to $52"}, {"Date": "2022-05-19", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$68 to $55"}], "Score": 0.86, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 14, "Period": "180 days", "Letter_Rating": "B", "Analists": ["JP Morgan", "Wells Fargo", "Deutsche Bank", "Barclays", "Oppenheimer", "Jefferies", "BofA Securities", "Credit Suisse", "Citigroup", "Morgan Stanley", "Piper Sandler", "Rosenblatt", "Evercore ISI", "UBS"], "Price_Target": 50.5}, "CLX": {"Ticker": "CLX", "Company": "Clorox", "Sector": "Consumer Staples", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$160"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Raymond James"], "Price_Target": 160.0}, "STZ": {"Ticker": "STZ", "Company": "Constellation Brands", "Sector": "Consumer Staples", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Redburn", "Rating_Change": "Buy", "Target_Change": ""}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Redburn"], "Price_Target": -1.0}, "ECL": {"Ticker": "ECL", "Company": "Ecolab", "Sector": "Materials", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$187"}, {"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$193 to $183"}, {"Date": "2022-06-03", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Neutral to Outperform", "Target_Change": "$180 to $195"}, {"Date": "2022-06-02", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$186 to $205"}, {"Date": "2022-05-20", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$205 to $180"}, {"Date": "2022-04-27", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$191 to $190"}], "Score": 1.17, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "B", "Analists": ["JP Morgan", "Wells Fargo", "BofA Securities", "Credit Suisse", "UBS"], "Price_Target": 190.0}, "EFX": {"Ticker": "EFX", "Company": "Equifax", "Sector": "Industrials", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$200"}, {"Date": "2022-04-21", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$340 to $200"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Wells Fargo", "Evercore ISI"], "Price_Target": 200.0}, "FFIV": {"Ticker": "FFIV", "Company": "F5 Networks", "Sector": "Information Technology", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$197 to $173"}, {"Date": "2022-04-27", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$210 to $200"}, {"Date": "2022-04-27", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$227 to $197"}, {"Date": "2022-04-27", "Rating": "Reiterated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$273 to $238"}, {"Date": "2022-04-27", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$255 to $220"}, {"Date": "2022-04-27", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$270 to $225"}, {"Date": "2022-04-27", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$265 to $240"}], "Score": 1.14, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 7, "Period": "180 days", "Letter_Rating": "B", "Analists": ["RBC Capital Mkts", "BofA Securities", "Loop Capital", "Credit Suisse", "Piper Sandler", "Evercore ISI"], "Price_Target": 213.29}, "FCX": {"Ticker": "FCX", "Company": "Freeport-McMoRan", "Sector": "Materials", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$48 to $28"}, {"Date": "2022-07-07", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2022-06-09", "Rating": "Upgrade", "Organization": "Credit Suisse", "Rating_Change": "Underperform to Neutral", "Target_Change": "$32 to $38"}], "Score": -0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Wolfe Research", "Credit Suisse", "Citigroup"], "Price_Target": 21.0}, "GPS": {"Ticker": "GPS", "Company": "Gap", "Sector": "Consumer Discretionary", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$12 to $9"}, {"Date": "2022-07-12", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$16 to $10"}, {"Date": "2022-05-27", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Underweight", "Target_Change": "$13 to $8"}, {"Date": "2022-05-27", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Underweight", "Target_Change": "$11 to $9"}, {"Date": "2022-05-23", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Sell", "Target_Change": "$13 to $8"}, {"Date": "2022-04-25", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": "$22"}, {"Date": "2022-04-18", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$14"}], "Score": -0.57, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 7, "Period": "180 days", "Letter_Rating": "D", "Analists": ["JP Morgan", "Wells Fargo", "Guggenheim", "Citigroup", "Morgan Stanley", "Deutsche Bank"], "Price_Target": 11.43}, "IT": {"Ticker": "IT", "Company": "Gartner", "Sector": "Information Technology", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$305"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Wells Fargo"], "Price_Target": 305.0}, "GILD": {"Ticker": "GILD", "Company": "Gilead Sciences", "Sector": "Health Care", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Cantor Fitzgerald", "Rating_Change": "Neutral", "Target_Change": "$70"}, {"Date": "2022-05-23", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform", "Target_Change": "$68"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["SVB Leerink", "Cantor Fitzgerald"], "Price_Target": 69.0}, "HBI": {"Ticker": "HBI", "Company": "Hanesbrands", "Sector": "Consumer Discretionary", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": ""}, {"Date": "2022-06-08", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$18 to $13"}, {"Date": "2022-05-06", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$26 to $13"}], "Score": -1.67, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Stifel", "Barclays", "Evercore ISI"], "Price_Target": 7.67}, "HAS": {"Ticker": "HAS", "Company": "Hasbro", "Sector": "Consumer Discretionary", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "E", "Analists": ["KeyBanc Capital Markets"], "Price_Target": -1.0}, "ILMN": {"Ticker": "ILMN", "Company": "Illumina", "Sector": "Health Care", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$350 to $150"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Barclays"], "Price_Target": 150.0}, "INTC": {"Ticker": "INTC", "Company": "Intel", "Sector": "Information Technology", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Neutral", "Target_Change": "$50 to $42"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Susquehanna"], "Price_Target": 42.0}, "JNPR": {"Ticker": "JNPR", "Company": "Juniper Networks", "Sector": "Information Technology", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Rosenblatt", "Rating_Change": "Neutral", "Target_Change": "$33"}, {"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Underweight", "Target_Change": "$34 to $27"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Piper Sandler", "Rosenblatt"], "Price_Target": 30.0}, "LKQ": {"Ticker": "LKQ", "Company": "LKQ Corporation", "Sector": "Consumer Discretionary", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "MKM Partners", "Rating_Change": "Buy", "Target_Change": "$68"}, {"Date": "2022-04-28", "Rating": "Upgrade", "Organization": "Barrington Research", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": ""}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Barrington Research", "MKM Partners"], "Price_Target": 33.0}, "TAP": {"Ticker": "TAP", "Company": "Molson Coors Beverage Company", "Sector": "Consumer Staples", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Upgrade", "Organization": "Redburn", "Rating_Change": "Sell to Neutral", "Target_Change": ""}, {"Date": "2022-06-28", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Sell to Neutral", "Target_Change": "$46 to $54"}, {"Date": "2022-06-21", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$60 to $54"}, {"Date": "2022-05-17", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$59"}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Bernstein", "UBS", "Goldman", "Redburn"], "Price_Target": 40.75}, "NVDA": {"Ticker": "NVDA", "Company": "Nvidia", "Sector": "Information Technology", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Reiterated", "Organization": "Susquehanna", "Rating_Change": "Positive", "Target_Change": "$260 to $220"}, {"Date": "2022-05-26", "Rating": "Resumed", "Organization": "The Benchmark Company", "Rating_Change": "Buy", "Target_Change": "$365 to $228"}, {"Date": "2022-05-03", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$217"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["The Benchmark Company", "Morgan Stanley", "Susquehanna"], "Price_Target": 221.67}, "REGN": {"Ticker": "REGN", "Company": "Regeneron Pharmaceuticals", "Sector": "Health Care", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Cantor Fitzgerald", "Rating_Change": "Neutral", "Target_Change": "$625"}, {"Date": "2022-06-06", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Underperform", "Target_Change": "$536"}, {"Date": "2022-05-23", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": "$738"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "SVB Leerink", "Cantor Fitzgerald"], "Price_Target": 633.0}, "ROL": {"Ticker": "ROL", "Company": "Rollins", "Sector": "Industrials", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$37"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Wells Fargo"], "Price_Target": 37.0}, "SHW": {"Ticker": "SHW", "Company": "Sherwin-Williams", "Sector": "Materials", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$313 to $292"}, {"Date": "2022-07-12", "Rating": "Upgrade", "Organization": "Northcoast", "Rating_Change": "Neutral to Buy", "Target_Change": "$300"}, {"Date": "2022-05-31", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Underperform", "Target_Change": "$245"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Credit Suisse", "Northcoast", "BofA Securities"], "Price_Target": 279.0}, "SYF": {"Ticker": "SYF", "Company": "Synchrony Financial", "Sector": "Financials", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$45 to $32"}, {"Date": "2022-05-12", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Underperform", "Target_Change": "$22"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Wells Fargo", "Wolfe Research"], "Price_Target": 27.0}, "TSLA": {"Ticker": "TSLA", "Company": "Tesla", "Sector": "Consumer Discretionary", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Resumed", "Organization": "Canaccord Genuity", "Rating_Change": "Buy", "Target_Change": "$801"}, {"Date": "2022-06-24", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$1125 to $1000"}, {"Date": "2022-06-13", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": "$1175 to $1100"}, {"Date": "2022-06-09", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$1100"}, {"Date": "2022-05-17", "Rating": "Upgrade", "Organization": "Tudor, Pickering, Holt & Co.", "Rating_Change": "Sell to Hold", "Target_Change": ""}, {"Date": "2022-05-10", "Rating": "Initiated", "Organization": "Berenberg", "Rating_Change": "Hold", "Target_Change": "$900"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Canaccord Genuity", "RBC Capital Mkts", "Berenberg", "Credit Suisse", "Tudor, Pickering, Holt & Co.", "UBS"], "Price_Target": 815.83}, "VRTX": {"Ticker": "VRTX", "Company": "Vertex Pharmaceuticals", "Sector": "Health Care", "Updated": "2022-07-13", "Rating": [{"Date": "2022-07-13", "Rating": "Initiated", "Organization": "Cantor Fitzgerald", "Rating_Change": "Overweight", "Target_Change": "$365"}, {"Date": "2022-06-01", "Rating": "Upgrade", "Organization": "Maxim Group", "Rating_Change": "Hold to Buy", "Target_Change": "$325"}, {"Date": "2022-05-23", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform", "Target_Change": "$265"}, {"Date": "2022-05-06", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$250"}, {"Date": "2022-05-03", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$250"}], "Score": 0.4, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Cantor Fitzgerald", "SVB Leerink", "Morgan Stanley", "Maxim Group", "Robert W. Baird"], "Price_Target": 291.0}}